News | January 30, 2026
Gland Pharma reports robust Q3 FY26 results: revenue up 22%, adj. PAT soars 37%
The base Gland business posted ?11,790 million in revenue, up 16% YoY
The base Gland business posted ?11,790 million in revenue, up 16% YoY
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
Vanda strongly disputes the FDA’s reasoning
The clearance marks a major step in Diabeloop’s ambition to become a central partner for insulin pump manufacturers and expand access to automated insulin delivery in the US market
The decision follows an interim analysis conducted when roughly half of the patients had completed their Day 84 visit
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
Subscribe To Our Newsletter & Stay Updated
